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Background: Prostate cancer (PCa) originating from the prostate base may intrude into the urinary bladder and
may be misdiagnosed as bladder cancer. In this retrospective study, we reviewed the clinic data on PCa cases
which were initially misdiagnosed as bladder cancer in order to identify diagnostic methods that would allow a
better differential diagnosis for PCa.
Methods: Out of a total of 455 patients treated for PCa at our hospital between April 2003 and June 2011, 14
patients (3.1%) had been initially misdiagnosed as urinary bladder urothelial cell carcinoma. The clinical data on
these 14 cases was retrieved and analyzed.
Results: Of the 14 patients, 11 patients were eventually diagnosed with PCa after MRI examination, and seven out
of these had PCa with bladder neck invasion. Prostate needle biopsy or transurethral resection of prostate (TURP)
revealed that all 14 patients had adenocarcinoma of prostate with Gleason scores ranging from 7 to 9. Nine
patients received TURP for hematuria or lower urinary tract blockage. The mean follow-up was 37 months, during
which six patients survived.
Conclusions: As clinical presentation and in emergency settings, prostate cancer originating from the prostate base
can be confused with bladder cancer originating from the neck or the triangle region of the urinary bladder. Serum
prostate specific antigen (PSA) levels and digital rectal examination, in combination with transrectal ultrasound
(TRUS), MRI, and prostate needle biopsy are valuable tools for definitive differential diagnosis of the basal prostate
cancer.
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The worldwide incidence of prostate cancer (PCa) is
ranked second amongst all the cancers in men, with a
mortality rate ranked sixth in the world. In many devel-
oped countries the incidence and mortality of PCa is
even higher [1]. Although the incidence of PCa in China
has been relatively low, in recent years it has shown an
increasing trend, probably due to an increase in the
aging population and changing life-styles. In general, at
diagnosis, most of the patients are over 50 years old with
mid-to-advanced stages of the disease. PCa affects the* Correspondence: xuyongtianjin1955@126.com
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reproduction in any medium, provided the orquality and expectancy of life, and is an increasingly im-
portant topic in the area of urology.
In terms of histopathology, McNeal et al. reported that
70% of the PCa tumors occur in the peripheral zone,
20% in the transitional zone and 10% in the central zone
[2]. The central zone is located in the back of the pros-
tate within the proximal urinary tract and displays an
upside-down cone shape, where the cone bottom consti-
tutes the base of prostate. PCa which originates from the
base of prostate may enlarge and protrude into the blad-
der and form a regional hunch in the neck, trigone and
posterior wall of the bladder. This is normally seen as
intra-bladder-protruding lumps on the coronal plane
during image examination and could be easily clinically
misdiagnosed as a bladder-occupying lesion.This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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extending into the urinary bladder can be easily mis-
diagnosed as bladder cancer. Only a few studies have in-
vestigated criteria that would allow distinction between
these two cancers [3-6]. The diagnostic tools used in
these studies included urine cytology, immunohisto-
chemistry and the use of molecular markers. In order to
improve the clinical differential diagnosis of PCa from
urinary bladder urothelial cell carcinoma, we reviewed
and analyzed the clinical data of the misdiagnosed PCa
cases. Clinical differential diagnosis using standard im-
aging, including transrectal ultrasound (TRUS) and CT
and/or cystoscopy is not the same as pathological differ-
ential diagnosis. Therefore, this review mainly included
the clinical findings, adjuvant diagnostic tests performed
subsequently, the treatment given and the follow-up.
The aim of this review was to identify the possible rea-
sons that led to the misdiagnosis as well as to identify
clinical diagnostic tools that allow distinction to be
made between these two cancers.
Methods
Patients
Records of all PCa cases treated between April 2003 and
June 2011 were reviewed to identify those that had been
initially misdiagnosed as urinary bladder cancer. Data of
clinically misdiagnosed cases which were later confirmed
as PCa were analyzed. This study was approved by the
Ethics Committee of the Institution in which it was
performed. Written informed consent was obtained from
every participant.
Clinical diagnostic methods
Routine tests that had been performed on all patients
were digital rectal examination (DRE), a blood test for
prostate-specific antigen (PSA), prostate needle biopsy
by the systemic 10-needle method, abdominal color
Doppler, exfoliative urine cytology with acridine orange
staining, and isotope emission computed tomography
(ECT) bone scan. Other clinical diagnostics tests that had
been performed on some of the patients included MRI,
transrectal ultrasound (TRUS) examination, 11C-Acetate
(11C-ACE) positron emission tomography-computer tom-
ography (PET-CT), intravenous urography (IVU), cysto-
scopic examination, and microscopic biopsy.
Results
Patient characteristics
A total of 455 cases were treated for PCa during the
eight year study period (2003 to 2011), and of these, 14
cases had been initially misdiagnosed as urinary bladder
cancer. Detailed clinical data for these 14 patients was
retrieved and analyzed. The age of the 14 patients ranged
from 54 to 80 years, with a mean age of 70.6 years(Table 1). In terms of clinical symptoms, 12 of the 14 pa-
tients had reported frequent micturition and urgency of
urination, eight had progressive dysuria due to bladder
outlet obstruction, three had gross hematuria, and two
patients reported intermittent painless gross hematuria
(Table 1). Ten of the fourteen patients presented to the
emergency department and four patients presented via the
outpatient department.
Of the 14 cases, PSA levels were 10 to 30 ng/ml in
four patients, 30 to 50 ng/ml in four patients, 50 to
100 ng/ml in three patients, and > 100 ng/ml in three pa-
tients, with an average value of 56.7 ng/ml (Table 1).
The DRE revealed a hard prostate in nine patients, a soft
prostate in five patients, second degree enlargement in
five patients, third degree enlargement in seven patients,
fourth degree enlargement in two patients, and palpable
lumps in five patients (Table 1).
Clinical adjuvant examinations
All 14 patients had been examined in the outpatient or
emergency department with abdominal color Doppler
ultrasound of the urinary system and had shown a
hypoechoic region within the bladder neck and trigone
(Figure 1). Furthermore, seven patients had mucosal
thickening in the bladder neck, trigone or posterior wall.
Therefore, all 14 patients were clinically considered to
have bladder-occupying lesions (Table 2).
The 14 cases showed varying degrees of prostate hyper-
trophy by ultrasound examination. The prostate size varied
between 27.9 and 118.6 ml. Nine patients received a rou-
tine CT examination that showed an irregular soft tissue
intruding into the bladder (Figure 2). Out of these nine,
five patients had bladder wall thickening, three showed a
blurred image in the trigone area and seminal vesicle, and
four displayed enlargement in the lymph nodes surround-
ing the iliac blood vessels. Thus, the CT results suggested a
bladder-occupying lesion. One case was considered to have
a prostate originated lesion (Table 2). TRUS was performed
for seven patients. Three of them showed a solid structure
which invaded into the bladder neck, two patients showed
a thickening of mucosa in the right bladder wall, and two
patients showed a reduced ultrasound echo in the posterior
subcapsular region of the prostate. Thus, a total of five pa-
tients were considered to have bladder-occupying lesions
while two were considered to have prostate-occupying le-
sions invading into the bladder neck (Table 2).
Exfoliative urine cytology examination by acridine or-
ange staining was positive for five of the 14 patients
(Table 1). A routine intravenous urography (IVU) applied
to eight patients, showed a bladder filling defect in two of
them, suggesting a bladder-occupying lesion (Table 2). A
routine cystoscopic examination performed on seven of
the patients had revealed protruding lumps on the bladder
neck and posterior wall. In general, the lumps had nodular
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DRE, digital rectal examination; PSA, prostate-specific antigen; TURP, transurethral resection of the prostate.
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case the node started from the posterior lip of bladder
neck and extended to the left ureteral orifice. Microscopic
biopsies were taken in two patients, and one patient
revealed an invasive low-grade differentiated adenocar-
cinoma, the other patient indicated transitional cell car-
cinoma. The isotope ECT bone scan showed multiple
bone metastases in six patients (Table 2).Clinical differential diagnosis
Of the 14 patients, 11 patients had undergone routine
MRI examination. Obscure boundaries between the cen-
tral and peripheral zones of the prostate were found in six
patients. Low signal nodular shadow from T2-weighted
images in the central or the peripheral zone was found in
five and four patients, respectively. Also, irregular, abnor-
mal signals of soft tissue shadow intruding into the
Figure 1 Abdominal color Doppler ultrasound showing hypoechoic region in the bladder neck and trigone with mucosal thickening in
the bladder neck, interpreted as a bladder-occupying lesion. (A) sagittal plane; (B) transverse plane. P: prostate; BL: bladder.
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ation of bladder lesions to prostate lesions on the sagittal
plane (Figure 3B) were found in nine patients. Blurred im-
ages were found in the trigone of the bladder and seminal
vesicle in four patients. Finally, loss of normal structures
in the prostate, with nodular protrusion, was found in five
patients. Thus, on the basis of MRI, seven patients were
considered to have PCa invading into the bladder, and
four were considered to have PCa (Table 2).
Prostate needle biopsy (systemic 10-needle) performed
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patients were diagnosed with high-grade prostatic intra-
epithelial neoplasia (HGPIN), but were later diagnosed
as PCa by TURP with Gleason score of 7. Of the 14
cases, six cases were categorized as cT4N1M1b, and eight
cases as cT4N0M0 (Table 1).
Two patients had undergone 11C-ACE PET-CT, which
indicated an enlarged prostate intruding into the bladder
with abnormally high metabolism, and multiple lymph
node enlargements in the pelvic cavity with abnormally
elevated metabolism (Figure 4).Bone ECT Intravenous
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Figure 2 CT indicates mucosal thickening in the bladder wall
and a shadow of soft tissue density in the bladder neck, which
was considered to be a bladder-occupying lesion. P: prostate;
BL: bladder.
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All 14 patients were late stage high-risk patients who
were not able to receive radical prostatectomy. Different
strategies were used to treat the patients (Table 2):
surgical castration in three patients, surgical castration
plus TURP in six patients, surgical castration plus anti-
androgen drug in one patient, TURP plus endocrine
therapy in three patients (maximum androgen block,
MAB) and endocrine therapy (MAB) plus chemother-
apy (prednisone + docetaxel) in one patient. In nine pa-
tients who received TURP due to lower urinary tract
blockage or hematuria, the Gleason score was revised
from 8 to 9 in two patients, and in two cases, the diag-
nosis was changed from HGPIN to PCa. TURP findingsFigure 3 MRI showing of one typical soft tissue. MRI T2-weighted imag
intrudes into the bladder on the transverse plane (A). The abnormal signal
on the sagittal plane (B). The lesion was considered to be PCa with bladdewere consistent with the biopsy results in the other five
patients.
Follow-up
Of the 14 patients, three were lost to follow-up and the
remaining patients were monitored for 12 to 56 months,
with an average follow-up duration of 32.4 months
(Table 1). Of the six patients who survived till the end of
the study period, two patients had well-controlled PSA
levels without any apparent lower urinary tract symptoms,
while four patients had uncontrolled high PSA levels and
were diagnosed as castration-resistant prostate cancer
(CRPC). These four CRPC patients were catheterized with
a urinary catheter that was periodically replaced in case of
dysuria. Of the 14 patients, five patients died due to mul-
tiple metastases, including bone, liver and brain metastasis.
Discussion
In this retrospective study, we attempted to identify
diagnostic techniques that proved to be useful in the
clinical differential diagnosis of PCa to distinguish it
from bladder cancer. Among the 455 PCa cases treated
at our hospital, 14 (3%) had been misdiagnosed because
the tumor was located in the base of the prostate and
extended into the bladder. We discuss the clinical find-
ings that aided in determining the correct differential
diagnosis in these 14 cases which relied on PSA, MRI,
microscopic biopsy, and 11C-ACE based PET-CT.
All of the 14 patients had received abdominal color
Doppler ultrasound examination of the urinary system,
which had revealed hypoechoic regions within the blad-
der neck and a protruded trigone extension into the
bladder. CT scan in nine patients had revealed an intra-
bladder, irregular soft tissue shadow. This was usually
considered as a bladder-occupying lesion from the clin-
ical point of view, though some prostate cancer could
also protrude into the bladder and form a bladder-e showing an irregular abnormal signal of soft tissue shadow that
shadow intruding into bladder is a continuation of the prostate lesion
r neck involvement.
Figure 4 11C-Acetate (11C-ACE) based PET-CT examination shows prostate enlargement intruding into the bladder with an abnormally
increased metabolism. Multiple lymph node enlargement (A, C, red arrow) accompanied by abnormally increased metabolism in the prostate
and lymph node (B, D) is also shown. P: prostate; BL: bladder.
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the lesion itself or its upper-front prostate tissue may
protrude into bladder. Furthermore, utilizing the axial
CT scan results, it is sometimes hard to locate the lesion
and the patients could be sometimes misdiagnosed as
having bladder cancer. In this study, all of the misdiag-
nosis was based on the interpretation of abdominal color
Doppler ultrasound and CT.
Prior to admission, these 14 patients were all clinically
diagnosed as having bladder-occupying lesions and were
examined with other adjuvant examination methodology
based on the consideration of having a bladder-occupying
lesion. In order to exclude upper urinary tract epithelial
cancer, eight of the patients received IVU, which did not
show any upper urinary tract filling defect.
Exfoliative urine cytology examination by acridine or-
ange is a simple, non-invasive examination that is
beneficial for the differential diagnosis of epithelial cell
carcinoma originated from bladder and urinary tract [7].
However, the examination results may be affected by
some subjective factors. Low-grade malignant tumor,
trauma and inflammatory cells are hard to distinguish
from one another and the false positive rate could be
15% to 30% [8]. At present, clinically performed exfolia-
tive urine cytology examination still focuses on the ob-
servation of cell morphology, which does not includeobservation of surrounding tissue structures. In general,
it is not easy to distinguish cancer cells and inflamma-
tory cells by standard staining and observation under
the light microscope. Urine samples of all 14 patients
had been examined by acridine orange fluorescent stain-
ing of exfoliated cells and the results indicated five posi-
tive cases. From a certain point of view, this result could
potentially mislead doctors to the diagnosis of urothelial
cell carcinoma rather than PCa. Therefore, the utility of
exfoliate cell examination is questionable for the differ-
ential diagnostic of PCa intruding into the bladder.
Krishnan and Truong [3] retrospectively studied 250
cases of high-grade carcinoma to identify clinical and
urine cytological features that would allow differential
diagnosis between prostate adenocarcinoma from transi-
tional cell carcinoma. Eight of these cases (3%) were
identified with PCa based on urine cytology at a fre-
quency similar to the present study. A total of seven pa-
tients were checked by routine cystoscopy. Occupying
lesions without typical papillary carcinoma findings in
the bladder neck and trigone were observed. Micro-
scopic biopsy was performed in two of the patients, one
of which was diagnosed as a transitional cell carcinoma.
Another case was diagnosed as invasive low-grade differ-
entiated adenocarcinoma, possibly of prostate origin.
Generally, when a tumor of prostate origin intrudes into
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lium. As the depth of biopsy is limited, the tissue taken
is usually from bladder transitional epithelial mucosa
above the tumor mass. Therefore, it is sometimes hard
in these cases to obtain an accurate diagnosis by biopsy
of a mass of prostatic origin, especially when the patient
has inflammation, atypical hyperplasia or in situ carcin-
oma of the bladder trigone [9,10].
From the symptomatic view point, most of the patients
in this study had lower urinary tract stimulation symp-
toms, while five patients had gross hematuria. These
clinical manifestations are similar to those of bladder
neck tumor infiltrating into deep muscular layer. There-
fore, this can lead into a misdiagnosis of bladder cancer
instead of prostate cancer.
At the international level, urologists commonly believe
that a routine PSA and DRE examination should be car-
ried out for males over 50 years of age with lower urinary
tract symptoms. PSA level measurement and DRE play
pivotal roles in the differential diagnosis of bladder cancer
from prostate cancer [11]. All of the patients had various
degrees of PSA elevation in this study. However, the serum
PSA level may be influenced by catheterization, urinary re-
tention or DRE. Meanwhile, high-grade (Gleason score 8
to 10) prostate cancer may have low (< 10 ng/ml ) or even
normal (< 3 ng/ml) serum PSA. The clinical differential
diagnosis became more difficult in this situation. There-
fore, urologists should consider the possible influence of
false positive PSA results in these situations. DRE was
performed in ten patients with five of them showing palp-
able lumps, which was an indication of PCa.
Among the imaging techniques, MRI appears to be
more useful in the diagnosis of PCa than CT scan. It can
provide multi-dimensional images and produce high reso-
lution axial images of both sides of the peripheral lobe and
the surrounding lesion. The lesions on the bottom and tip
of prostate are easily observed on the coronal and sagittal
plane and T2-weighted MRI images [12]. A total of 11 pa-
tients in this group were routinely examined by MRI. In
nine patients, an irregular abnormal soft tissue shadow
protruded into the bladder and connected with the lesion
in the prostate on the sagittal plane. Therefore, they were
diagnosed as PCa based on MRI. Also, seven patients were
diagnosed as having PCa with bladder involvement. The
other four patients were diagnosed as PCa. The results
were consistent with the final pathological diagnosis.
However, MRI is expensive, operator dependent, and time
consuming with some limitations, especially in the emer-
gency setting. Therefore, we suggest that TRUS performed
by an expert operator is the first approach to study the
prostate anatomy. Based on TRUS findings, further im-
aging is required or prostate biopsy is performed.
PET-CT has a very important role in localization and
distinguishing of the malignant tumor and its metastases[13]. Two of the patients were examined with 11C-ACE-
based PET-CT scan, which further confirmed that the le-
sions originated from the prostate and had pelvic lymph
node metastasis. However, PET-CT is expensive and
cannot replace needle biopsy, and is therefore not an es-
sential item for diagnosis.
Prostate needle biopsy is the most reliable examination
for the diagnosis of PCa [14]. In this study, because all
of the 14 patients had high levels of PSA, they were
checked by transrectal prostate needle biopsy using the
systemic 10 needle method. The results indicated PCa in
12 of them, and HGPIN in two of them. Furthermore,
TURP was performed in the latter two patients because
of dysuria, which indicated PCa. The reason for misdiag-
nosis of a biopsy may be that the tumor originated from
the central lobe and protruded into the bladder and so
the routine transrectal needle biopsy cannot reach the
tumor position. Therefore, transperineal template-guided
saturation biopsy should be considered when the suspect
tumor is in the central zone or anterior region [15].
McNeal et al. [16] have reported that PCa originating
from the transitional region is usually diagnosed by
TURP examination. In this study, we focused on PCa
originating from the central lobe and undertook examin-
ation with TURP to avoid misdiagnosis. All of the 14 pa-
tients were late-stage and high-risk patients and were
primarily treated with endocrine therapy. Furthermore,
nine patients were treated with TURP for hematuria or
lower urinary tract blockage. Eleven patients were regu-
larly checked during the follow-up. Six patients survived
during the follow-up period; however, four patients
progressed to CRPC. These findings demonstrated that
PCa originating from the central lobe has tendencies to
bladder neck infiltration and remote metastasis. There-
fore, it has a low curative potential and a relatively bad
prognosis.
Conclusions
Taken together, the data presented here suggest that
when lesions are found in the neck, trigone or posterior
wall of the urinary bladder, the possibility of basal pros-
tate cancer should be considered. For the middle aged
and elderly male patients with lower tract blockage, blad-
der stimulation, bone pain, hematuria and other symp-
toms, routine PSA and DRE examinations should be
performed. TRUS or MRI examination is suggested when
necessary. During imaging, it is important to look for a
prostate with an enlarged basal region protruding into the
bladder, and a prostate with a disorganized structure.
Furthermore, it is important to examine whether the
symmetry is disrupted, whether the capsule is intact. A
multi-view analysis can clinically reduce the rate of PCa
misdiagnosis. Finally, prostate biopsy should also be
performed when prostate cancer is suspected.
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